Excretion of organic acids associated with biotin deficiency in chronic anticonvulsant therapy by Krause, Klaus-Henning et al.
Band 54 1 9 8 ^ 
International Journal for Vitamin and Nutrition Research 
Internationale Zeitschrift 
für Vitamin- und Ernährungsforschung 
Journal international de Vitaminologie et de Nutrition 
E D I T O R - I N - C H I E F 
G. R I T Z E L , ST. A L B A N V O R S T A D T 19, CH-4052 B A S E L 
C U R A T O R E S 
K. Bernhard, Basel R.S. Harris, Cambridge, Mass. R.E. Stone, Chicago 
H . D . Cremer, Glessen C. den Hartog, Wageningen A . V . Szent-Györgyi , Woods Hole 
K. Folkers, Austin T. Reichstein, Basel 
E D I T O R E S 
J.T. Abrams, Cambridge, GB 
H . Berger, Innsbruck 
H.Bicke l , Zürich 
A . Bondi, Rehovoth 
M . Brin, Nutley 
G. Brubacher, Basel 
R. Buzina, Zagreb 
D.B. Coursin, Lancaster 
P.M.Dreyfus, Sacramento 
F. Fidanza, Perugia 
J. Ganguly, Bangalore 
J. Mauron, La Tour-de-Peilz 
H . E . Sauberlich, Birmingham, USA 
M.L .Sco t t , Ithaca 
The "International Journal for Vitamin and Nutri t ion Research" is published at irregular intervals 
(about 4 fasc. per annum) 4 fasc. = 1 volume, prize per volume= Sw.Fr. 134.— / Die «Internat ionale 
Zeitschrift für Vitamin- und Ernährungsforschung» erscheint in zwangloser Reihenfolge (ca. 4 Hefte pro 
Jahr). 4 Hefte ergeben einen Band. Bezugspreis pro Band = sFr. 134.—, D M 170.— / Le «Journa l inter-
national de Vitaminologie et de Nutr i t ion» parait irregulierement en fascicules (env. 4 fasc. par annee). 
4 fasc.= 1 volume, prix par volume = sfr. 134.— 
Hans Huber Publishers Berne Stuttgart Toronto 
Western Hemisphere: Jack K. Burgess Inc., 2175 Lemoine Avenue, Fort Lee, N . J . 07024 
This Journal is regularly listed in Current Contents and Index Medicus 
The Journal serves as the official organ of the Swiss Society for Nutr i t ion Research 
Printed in Switzerland © 1984 by Hans Huber Publishers, Berne 
Inhalt / Contents 
A R A F A A . M . and HUSSEIN L . : The Assessment of The Vitamin B 6 Status among Egyptian School 
Children by Measuring the Urinary Cystathionine Excretion 321 
A R I M A N A N A L . and L E A T H W O O D P . D . : Effects of Prior Carbohydrate Intake on Protein/Carbo­
hydrate Selection by the Rat 283 
A R N A U D M . J . , WELSCH C , GARREL D . and TOURNIAIRE J.: Reproducibility of the Measurement 
of Whole Body Protein Turnover Using the End Product Method 282 
BASU T . K . , WEISER, Τ . and DEMPSTER J.F.: An in vitro Effect of Ascorbate on the Spontaneous 
Reduction of Sodium Nitrite Concentration in a Reaction Mixture 233 
BAYLISS R . M . , BROOKES R . , M C C U L L O C H J., K U Y L J . M . and M E T Z J.: Urinary Thiamine Excretion 
after Oral Physiological Doses of the Vitamin 161 
B I C K E L R . , REINHARDT C . A . and L Ü T H Y J.: In vitro Growth Inhibition Assay for the Detection of 
Fusarium Toxins in Feedstuffs 287 
BIESALSKI H . K . : Retinol and Retinyl Ester in Separated Structures of the Guinea Pig Inner Ear . . . 113 
B L U M M . , PRABUCKI A . L . and SCHÜRCH Α . : The Influence of Different Dietary Fats on the Life 
Span of Rats 276 
B L U M M . , PRABUCKI A . L . and SCHÜRCH Α . : The Influence of Various Dietary Fats on the Fatty 
Acid Composition of Organ Lipids in the Rat 277 
BONJOUR J.-P., BAUSCH J., SUORMALA T . and BAUMGARTNER E . R . : Detection of Biocytin in Urine 
of Children with Congenital Biotinidase Deficiency 223 
BOUCHER-EHRENSPERGER M . and PETTER C : Prevention of Thrombocytic Defects in the br /br 
Rabbit with Folic acid and Vitamin B 1 2 : Analogy with the T . A . R . Syndrome in Humans 199 
BRANCA D . , SCUTARI G . and SILIPRANDI N . : Pantethine and Pantothenate Effect on the CoA Con­
tent of Rat Liver 211 
CASTER W . O . , D R U M M O N D S . K . and T A N N E R M . A . : Maternal Diet and Mental Retardation in 
Southern Georgia, USA 371 
CHANGBUMRUNG S., POSHAKRISHANA P. , V U D H I V A I N . , HONGTONG K. , PONGPAEW P . , M I G A S E N A 
P . et ah Measurements of B H B 2 , B 6 Status in Children and their Mothers Attenting a Well-
baby Clinic in Bangkok 149 
C U L L U M M . E . , OLSON J . A . and VEYSEY S.: Analysis of Deuterated Analogs o f Vitamin A by Elec­
tron Impact and Chemical Ionization Modes in Gas Chromatography Coupled to Mass Spec­
trometry 3 
C U L L U M M . E . , JOHNSON C . and Z I L E M . H . : Comparison of Fetal and Adult Retinol and Retinoic 
Acid Binding Proteins in Bovine Serum and Pigment Epithelium 297 
C U L L U M M . E . , Z I L E M . H . and VEYSEY S .W. : Analysis of Retinol and Dideuterated Retinol in Rat 
Plasma by Gas Chromatography Combined Mass Spectrometry 11 
DECOMBAZ J., SARTORI D . , A R N A U D A . L . , T H E L I N A . L . , SCHÜRCH P . and H O W A L D H . : Oxidation 
and Metabolic Effects of Fructose or Glucose Ingested before Exercise in Man 281 
DOREA J .G. , SOUZA J .Α. , GALVÄO Μ . Ο . and IUNES Μ . Α . F . : Concentration of Vitamin A in the 
Liver of Foetuses and Infants dying of Various Causes in Brasilia, Brazil 119 
F I D A N Z A A . A . : Nutritional Status of the Elderly, IV 361 
F I D A N Z A F . , BRUBACHER G., SIMONETTI M . S . and C U C C H I A L . M . : Nutritional Status of the Eld­
erly, I I I 355 
F I D A N Z A F . , F IDANZA A . A . , C O L I R . and M E N C A R I N I C . A . : Food and Nutritient Consumption of 
Two Rural Italian Population Groups Followed for Twenty Years 91 
F I D A N Z A F . , SIMONETTI M . S . , C U C C H I A L . M . , BALUCCA G.G. and LOSITO G.: Nutri t ional Status of 
the Elderly, I I 75 
FISHBAINE B . and BUTTERFIELD G.: Ascorbic Acid Status of Running and Sedentary Men 273 
F L A T T J . P . , ACHESON K. J . , RAVUSSIN E. and JEQUIER E.: Dietary Fat Substrate Utilization and 
Short Term Body Composition Changes in Man 279 
F L O R I D I Α. , PUPITA M . , P A L M E R I N I C.A. , F I N I C. and F I D A N Z A A . A . : Thiamin Pyrophosphate De­
termination in Whole Blood and Erythrocytes by High Performance Liquid Chromatography . 165 
FRIGG M . and BROZ J.: Relationships between Vitamin A and Vitamin Ε in the Chick 125 
GIBSON J . and W E S T H U Y Z E N J . VAN DER: Effect of L-Dihydroxyphenylalanine (L-dopa) and Met-
hionine on Tissue S-Adenosylmethionine Concentrations in Cobalamin-inactivated Fruit Bats . 329 
G L E N N B.P. and E L Y D.G. : Effect of Lipid-coated Lysine on Digestion and Nitrogen Metabolism 
by Wethers 377 
GRECO A . M . , BOSCHI G. , STICCHI R., V E T R A N I A . and SALVATORE G.: Effects of a Purified Diet 
Enriched with Animal Protein on Female Rats. Preliminary Report 263 
G U I D O U X R.: C a 2 + Regulation by Isolated Rat Liver Mitochondria Influence of the Intramito-
chondrial Citrate Content on the Extramitochondrial C a 2 + Level 288 
G U I G O Z Y . and JUILLERAT M . : Induction of Tyrosine Aminotransferase (TAT) by a Physiological 
Stress as Function o f Dietary Fat 289 
G U I L L A N D J .C . , BEREKSI-REGUIG B. , LEQUEU B. , M O R E A U D. and KLEPPING J.: Evaluation of Py-
ridoxine Intake and Pyridoxine Status among Aged Institutionalised People 185 
H I D I R O G L O U M . and W I L L I A M S C.J. : Vitamin D 3 Levels in Certain Sheep Tissues at Various Times 
after the Intramuscular Administration of Vitamin D 3 17 
H O L L O W AY D.E . , G U I R Y V.C. , HOLLOWAY B.A. and RIVERS J . M . : Influence of Dietary Ascorbic 
Acid on Cholesterol 7-a-Hydroxylase Activity in the Rat 333 
H O L M J. , H A N S E N I . and LYNGBYE J.: Quantitative and Qualitative Effects o f N 1 0 -Methylfolate on 
High-affinity Folate Binding in Human Leukocytes 195 
H O R I U C H I S. and O N O S.: Effects of Riboflavin Administration on the Phospholipid Metabolism 
o f Rat Liver Impaired with Carbon Tetrachloride 173 
H U N T C , C H A K R A V O R T Y N . K . and A N N A N G.: The Clinical and Biochemical Effects of Vitamin C 
Supplementation in Short-stay Hospitalized Geriatric Patients 65 
KIRCHGESSNER M . and M Ü L L E R H . L . : Thermogenesis with a Ketogenic Diet in Sows 99 
KORPELA H . , L O U E N I V A R., Y R Ä N H E I K K I Ε . and KAUPPILA Α. : Selenium Concentration in Mater­
nal and Umbilical Cord Blood, Placenta and Amniotic Membranes 257 
K R A T Z I N G C.C., K E L L Y J . D . and OELRICHS B .A . : Ascorbic Acid Changes in Brain 349 
K R A U S K . - H . , BONJOUR, J.-P. and B E R L I T P.: Biotin Levels in Plasma of Patients with Friedreich 
Ataxia and Other Spinocerebellar Degenerations 272 
KRAUSE K . - H . , K O C H E N W., BERLIT P. and BONJOUR J.-P.: Excretion of Organic Acids Associated 
with Biotin Deficiency in Chronic Anticonvulsant Therapy 217 
K U M P U L A I N E N J., V U O R I E. and SIIMES M . A . : Effect of Maternal Dietary Selenium Intake on Sele­
nium Levels in Breast Milk 251 
K U N Z C , NIESEN Μ . , L ILIENFELD-TOAL L . V O N , and BURMEISTER W.: Vitamin D , 25-Hydroxy-
Vitamin D and 1,25-Dihydroxy-Vitamin D in Cow's M i l k , Infant Formulas and Breast Mi lk 
during Different Stages of Lactation 141 
LABADARIOS D . , SHEPHARD G.S., M I N E U R L . G . , V A N B U U R E N A . J . , HUTCHISON M . E . and OOST-
HUIZEN O.J.: Biochemical Vitamin B 6 Deficiency in Adults with Chronic Glomerulonephrides 
with and without the Nephrotic Syndrome 313 
L A N G H A N S W. and SCHARRER E.: Feeding Rats a High Fat Diet Changes the Effect of Various Me­
tabolic Challenges on Food Intake 280 
MOSER U . and W E B E R F.: Uptake of Ascorbic Acid by Human Granulocytes 47 
M O E N N O Z D . and A S H L E Y D.V. : Comparison of Plasma Free Tryptophan and Plasma Tryptophan 
to Large Neutral Amino Acid Ratios as Physiological Predictors of Brain Tryptophan 285 
M O E N N O Z D . , E X E L L N . and ASHLEY D.V. : Lack of Influence o f Free Fatty Acids on Tryptophan-
albumin Binding in Plasma 286 
NADIGER H . A . , R A D A.S . and SADASIVUDU B. : Effect of Simultaneous Administration of Vitamin 
Ε and Pyridoxin on Erythrocyte Membrane Na + Κ "ATPase Activity 307 
OELRICHS B . A . , K R A T Z I N G C.C., K E L L Y J.D. and W I N Z O R D.J . : The Binding of Ascorbate to Bovi­
ne Serum Albumin 61 
PIIRONEN V. , V A R O P., SYVÄOJA E.-L. , SALMINEN K. , KOIVISTOINEN P. and A R V I L O M M I H , : High 
Performance Liqu id Chromatographic Determination o f Tocopherols and Tocotrienols and its 
Application to Diets and Plasma of Finnish Men, I I 41 
PIIRONEN V . , V A R O P., SYVÄOJA E.-L. , SALMINEN K. and KOIVISTOINEN P.: High Performance L i -
quid Chromatographic Determination of Tocopherols and Tocotrienols and its Application to 
Diets and Plasma o f Finnish Men, 1 35 
K . - H . KRAUSE et al: Biotin-dependent organic aciduria in anticonvulsant therapy 
Internat. J. Vi t . Nutr. Res.54 
(1984) 217-222 
Received for publication 
October 14, 1983 
Anticonvulsants 
Biotin deficiency 
Biotin-dependent organic aciduria 
Excretion of Organic Acids Associated with Biotin Deficiency 
in Chronic Anticonvulsant Therapy* 
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Summary: Urinary organic acids, known to be elevated in children with biotin 
deficiency, were determined in 7 epileptics under long-term therapy with anticon-
vulsants and in three controls. Four patients administered phenytoin, primidone, 
phenobarbital, or carbamazepine, alone or in combination, had reduced plasma 
biotin levels (<250 ng/l) and an elevated excretion of certain organic acids in-
dicating a possibly decreased activity of propionyl CoA carboxylase (3-OH-
propionate, methylcitrate) and 3-methylcrotonyl CoA carboxylase 
(3-methylcrotonate and the glycine conjugate, 3-OH-isovalerate). Two epileptics 
receiving sodium valproate alone had normal circulating biotin levels and no 
changes in level of the investigated urinary acids were found. These findings indi-
cate that the reduced biotin levels seen in epileptics receiving other anticonvulsants 
than sodium valproate lead to an elevated excretion of certain organic acids in 
urine. 
In the urine of patients with an inborn error of metabolism of biotin-dependent 
carboxylases elevated concentrations of organic acids (e.g. methylcitrate, 
3-hydroxypropionate, propionylglycine, tiglic acid, 3-methylcrotonic acid, 
3-hydroxyisovaleric acid) are found [1]. These metabolites are excreted due to a 
blockage in the catabolism of branched chain amino acids and are caused by a 
reduced activity of the biotin-dependent enzymes propionyl C o A carboxylase and 
3-methylcrotonyl C o A carboxylase (Figure 1). 
* This study was supported in part by grant Kr 659/1 from the Deutsche Forschungsgemeinschaft. 
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Pyruvate carboxylase deficiency has also been described as being accompanied by 
a typical urinary pattern, especially by an elevation of lactic acid [13] (Fig. 1). The 
regulation of fatty acid synthesis at the acetyl C o A carboxylase step is well known 
but its clinical relevance has not yet been elucidated. A deficient holocarboxylase 
synthetase, which attaches biotin to the apocarboxylase, or reduced circulating 
biotin levels due to an altered absorption, transport, and/or metabolism of biotin 
can be the reasons for the reduced carboxylase activities in patients with an inborn 
error of metabolism [1]. Some of the above mentioned organic acids have also been 
reported in the urine of a boy with a dietary biotin deficiency [9] and in a girl with 
short-gut syndrome during parenteral alimentation without biotin [8]. In both pa­
tients low circulating biotin levels and a reduced activity of biotin-dependent en­
zymes were found. 
A marked reduction of plasma biotin concentrations has been noted in epileptics on 
long-term therapy with anticonvulsants [6, 7]. The purpose of this study was to eva­
luate whether epileptics with low plasma biotin levels also excrete abnormal organic 
acids in their urine. 
Patients and methods 
24-h-samples o f urine were collected from seven long-term treated epileptics and from three controls 
(two males, aged 30 and 34 years, one female, aged 27 years). The clinical data of the patients are sum­
marized in Table I . In the morning after urine collection blood was taken for the microbiological deter­
mination of plasma biotin levels, using Lactobacillus plantarum as test organism [4], and for measuring 
serum concentrations of anticonvulsants. 
Tab. 1: Clinical data of the patients 
Patient age 
(years) 
sex type of seizures anticonvulsants duration of 
treatment 
(years) 
daily intake at lime 
of examination 
(mg/kg 
body weight) 
A 25 male partial seizures with 
complex symptomatology 
and tonic-clonic seizures 
Phenytoin 
phenobarbital 
24 
24 
4.2 
1.0 
B 37 ma/e partial seizures with 
complex symptomatology 
primidone 
carbamazepine 
12 
2 
10.1 
13.5 
C 28 male tonic-clonic seizures Phenytoin 1 4.8 
D 30 male partial seizures with 
complex symptomatology 
and tonic-clonic seizures 
Phenytoin 
carbamazepine 
0.1 
5 
5.4 
none 
Ε 24 female complex absences, partial 
seizures with complex 
symptomatology and 
tonic-clonic seizures 
Phenytoin 
sodium valproate 
7 
10 
5.8 
34.6 
F 25 male tonic-clonic seizures sodium valproate 3 15.6 
G 22 male tonic-clonic seizures sodium valproate 3 9.8 
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Determination of organic acids, which are known to be involved in inborn errors of biotin-dependent en­
zymes, or nutritional biotin deficiency, was carried out by combined gaschromatography and mass spec­
troscopy: Aliquots of the urines containing 5 mg of creatinine were lyophilized, then acidified to pH 2,5 
with H 2 S 0 4 and separated on a column of silicic acid into 4 fractions using 2-methyl-2-butanol/chloro-
form mixtures as eluents {5). 
The fractions were evaporated until dry, following which the TMS derivatives formed by addition of 
MSTFA (Machery & Nagel) were analyzed by GC/MS on a 50 m glass-capillary SE-54 (Jaegi, Trogen, 
Switzerland) with a Du Pont 21-492 Β mass-spectrometer (Programm 75° (10 min), 4 ° / m i n up to 220° 
C). Identification and quantification were performed by multiple specific ion detection (MSID) of the 
characteristic mass-ions of the acids to be measured. Calibrations o f the available reference compounds 
were performed as for samples. The internal standards (dibutylacetic acid and C , 9 alkane) were added 
after silicic acid chromatography and before evaporation of the chromatographic fraction. Reference 
compounds were not available for 3-methylglutaconic acid and propionylglycine. Identification of both 
compounds was confirmed by mass-spectrometric analyses of enriched samples. For quantification of 
propionylglycine (m/z 159) isobutyrylglycine (m/z 158) was used as reference due to the almost equal in­
tensities of the mentioned mass-ions. In the case of 3-methylglutaconic acid (eis + trans) 3-methylglutaric 
acid was applied using the M + -15 mass-ions for quantification; probable error was assumed to be less 
than ± 3 0 % . 
Results and Discussion 
The results of the determination of organic acids in urine are summarized in table 
I I , together with the serum concentrations of anticonvulsants and the plasma biotin 
levels. As expected from our previous study [7], plasma biotin levels in the five 
epileptics (patients A - E ) treated with phenytoin, primidone, phenobarbital or car-
bamazepine were clearly lower than in the two patients receiving sodium valproate 
alone ( F 4- G ) or in the three controls. Four of the five epileptics ( Α - D ) had a reduc­
ed plasma biotin concentration of less than 250 ng/1. 
A deficient activity of the propionyl C o A carboxylase might be deduced from 
elevated amounts of methylcitric acid and 3-OH-propionic acid in 3 cases (A, B, C ) . 
In contrast to our controls, propionylglycine could be detected in 2 patients (A, C ) . 
The excretion rates of tiglic acid and its glycine conjugate are too small to result in a 
clear indication, although the highest values of tiglic acid have been found in pa­
tients A and B. 3-OH-2-methylbutyric acid was distinctly elevated only in patients Β 
and C . A possibly influenced activity of the 3-methylcrotonyl C o A carboxylase was 
indicated by elevation of 3-OH-isovaleric acid in 3 cases (A, B, C ) , of 
3-methylcrotonic acid in 4 cases (A, B , C , D) and of its glycine conjugate in patients 
Β and D . The determinations of the metabolites following the 3-methylcrotonyl 
C o A carboxylase reaction (see Fig. 1) revealed, that in one patient (C) both 
metabolites were absent; in 2 other (B, D) 3-OH-3-methylglutaric acid was detec­
table in very little amounts, whereas the precursor was shown to be absent. High 
values of lactic acid were found in patients Α - D ; that seems to be consistent with 
decreased activity of the pyruvate carboxylase. 
Little is known about the connection between reduced biotin levels and changes in 
excretion of metabolites in consequence of decreased activity of carboxylases [1, 8, 
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, Ψ j^tmlic acid 
J «.g'y - c o A < ^ l y l g l y c i n e 
3 - m e t h y l c r o t o n y l g l y c i n e , ^ ^ J, φ 
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Fig. I : Metabolic pathways involving biotin-dependent carboxylases (3-MCC = 3-methylcrotonyl CoA 
carboxylase, PCC = propionyl CoA carboxylase, PC = pyruvate carboxylase, ACC = acetyl CoA car­
boxylase) 
9, 11]. Both the pattern and the concentration of organic acids excreted in urine 
were found to vary greatly in children with an inborn error of biotin-dependent en­
zymes, being dependent on protein intake or clinical status [1]. Therefore, not so 
much the individual concentrations or the pattern of organic acids excreted seem to 
be important, but the fact that in the urine of the epileptics under phenytoin, 
primidone, phenobarbital, or carbamazepine treatment, indications are given of 
higher levels of some organic acids possibly demonstrating a deficient activity of the 
carboxylases, especially of the propionyl C o A carboxylase, in which several increas­
ed metabolites support the assumption. In contrast, the 2 patients ( F and G ) on 
sodium valproate monotherapy exhibited no excretion rates indicating a possibly 
reduced activity of the carboxylases. As their plasma biotin levels were found to be 
normal a reduced enzymatic activity would not be expected. The reduced activity of 
the 3-methylcrotonyl C o A carboxylase in patients B, C and D seems furthermore to 
be indicated by the lower excretion of 3-methylglutaconic acid and 3-hydroxy-3-
methylglutaric acid, which appear after the carboxylation step in the catabolism of 
leucine, when compared to controls. 
The results of patient E , treated with sodium valproate and additional phenytoin, 
were intermediate between those of controls and epileptics given sodium valproate 
alone and those of the remaining epileptics: 3-hydroxyisovaleric acid and tiglic 
acidwere found to be higher in the urine of patient E . The excretion of 
3-methylglutaconic acid and of 3-hydroxy-3-methylglutaric acid was comparable to 
that of patients F and G . These findings indicate that the activity of the biotin-
Tab. H: Concentrations of anticonvulsants (PHT = phenytoin, PB = phenobarbital, P R M = primidone, CBZ 
in serum, biotin in plasma and organic acids in urine (μ ιηοΐ /mg creatinine) (n.d. 
= carbamazepine, VPA = sodium valproate) 
= not detectable) 
patients 
A Β c D Ε F G 
controls 
1 2 3 
normal values 
from the literature 
anticonvulsants PHT 6.1 
in serum ^ g / m l ) PB 9.9 
PRM 8.1 
PB 30.0 
CBZ 7.6 
P H T 12.6 P H T 46.2 VPA 53.6 
P H T 15.6 
VPA 75.4 VPA 50.7 — — — 
biotin in plasma 
(ng/L) 
< 150 240 197 198 280 343 325 327 305 413 >250 [7] 
propionylglycine 0.004 n.d 0.002 n.d. n.d. n.d. n.d. n.d. n.d. n.d. <0.01 [10] 
methylcitric acid 0.07 0.03 0.05 trace n.d. trace n.d. n.d. n.d. n.d. <0.01 [10] 
3-hydroxypro-
pionic acid 
0.025 0.03 0.09 trace trace n.d. n.d. n.d. 0.001 n.d. <0.01 [3] 
3-hydroxy-2-me-
thylbutyric acid 
0.004 0.04 0.03 0.004 0.004 0.005 0.008 n.d. 0.003 0.002 
tiglic acid 0.003 0.003 n.d. n.d. 0.001 n.d. n.d. n.d. trace n.d. <0.001 [10] 
tiglylglycine n.d. trace n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. <0.01 [10] 
3-methylcrotonic 
acid 
0.01 0.05 0.02 0.04 n.d. 0.004 n.d. n.d. trace n.d. 
3-methylcro-
tonylglycine 
n.d. 0.09 trace 0.03 n.d. n.d. n.d. n.d. n.d. n.d. <0.01 [11] 
3-hydroxyiso-
valeric acid 
0.37 0.42 0.22 0.15 0.17 0.06 0.06 0.03 0.01 0.1 <0.09[2] 
3-methylglu­
taconic acid 
trace n.d. n.d. n.d. 0.005 0.01 0.006 trace trace trace 
3-hydroxy-3-me-
thylglutaric acid 
0.01 trace n.d. 0.002 0.03 0.03 0.02 0.01 0.003 0.02 <0.01 [10] 
lactic acid 0.74 0.61 0.65 0.84 0.3 0.4 0.35 0.19 0.15 0.3 <0.22 [12] 
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dependent enzymes is less reduced in patient Ε than in the epileptics treated with an­
ticonvulsants other than sodium valproate; this is in accordance with the in­
termediate plasma biotin level of 280 ng/1 detected in patient E . 
For the first time an elevated excretion of some organic acids, known to occur in 
the urine of children with an inborn error of metabolism of biotin-dependent en­
zymes or of children with a dietary biotin deficiency, has been detected in epileptics 
treated with phenytoin, primidone, phenobarbital or carbamazepine. This elevated 
excretion seems to be caused by the reduced circulating biotin levels found in these 
epileptics. Whether a connection exists between the reduced plasma biotin levels and 
the anticonvulsant efficacy of these drugs remains to be studied. 
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